Literature DB >> 23672718

Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature.

Philip A Hodnett1, David P Naidich.   

Abstract

Establishing the etiology of fibrosing interstitial lung disease (FILD) remains a clinical challenge. This is because many disorders resulting in lung fibrosis may be similar in their initial clinical and radiographic appearances. High-resolution computed tomography (HRCT) studies are now almost always obtained for patients who present with otherwise nonspecific clinical symptoms and chest radiographic findings. In the majority of cases presenting with FILD, differential diagnosis typically requires differentiating among three most commonly encountered clinical entities: idiopathic pulmonary fibrosis with usual interstitial pneumonia, nonspecific interstitial pneumonia, and chronic hypersensitivity pneumonitis. As a consequence, the development of a simplified diagnostic algorithmic approach initially focusing on the interpretation of HRCT findings may prove of considerable value provided thorough familiarity with optimal HRCT techniques and methods of interpretation. For this purpose, in patients with FILD in whom an underlying etiology is not initially apparent, the recently proposed American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association guidelines for the diagnosis of IPF have been modified to create a straightforward, clinically practicable algorithmic approach to clinical management based on the initial interpretation and classification of HRCT findings.

Entities:  

Mesh:

Year:  2013        PMID: 23672718     DOI: 10.1164/rccm.201208-1544CI

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

1.  Predictive factors for the effect of pirfenidone in idiopathic pulmonary fibrosis.

Authors:  Yasunori Ichimura; Kenji Tsushima; Takuma Matsumura; Kazutaka Yamagishi; Mitsuhiro Abe; Jun Ikari; Jiro Terada; Koichiro Tastumi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

2.  The ten diseases that look like ARDS.

Authors:  Claude Guérin; Taylor Thompson; Roy Brower
Journal:  Intensive Care Med       Date:  2014-12-20       Impact factor: 17.440

Review 3.  Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.

Authors:  Margaret L Salisbury; Jeffrey L Myers; Elizabeth A Belloli; Ella A Kazerooni; Fernando J Martinez; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

4.  High-resolution computed tomography and magnetic resonance imaging protocols in the diagnosis of fibrotic interstitial lung disease: overview for "non-radiologists".

Authors:  Gianluigi Sergiacomi; Luca Pugliese; Francesca Ricci; Roberto Floris; Armando Fusco
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

5.  Clinical and molecular features of rapidly progressive chronic hypersensitivity pneumonitis.

Authors:  Yasushi Horimasu; Nobuhisa Ishikawa; Hiroshi Iwamoto; Shinichiro Ohshimo; Hironobu Hamada; Noboru Hattori; Morihito Okada; Koji Arihiro; Yuji Ohtsuki; Nobuoki Kohno
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 6.  Keeping it together: Pulmonary alveoli are maintained by a hierarchy of cellular programs.

Authors:  Catriona Y Logan; Tushar J Desai
Journal:  Bioessays       Date:  2015-07-22       Impact factor: 4.345

7.  Bronchoscopic Probe-Based Confocal Laser Endomicroscopy to Diagnose Diffuse Parenchymal Lung Diseases.

Authors:  Edith Silbernagel; Elvira Stacher-Priehse; Julien Dinkel; Herbert Stepp; Wolfgang Gesierich; Michael Lindner; Juergen Behr; Frank Reichenberger
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

8.  Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.

Authors:  Margaret L Salisbury; Meng Xia; Susan Murray; Brian J Bartholmai; Ella A Kazerooni; Catherine A Meldrum; Fernando J Martinez; Kevin R Flaherty
Journal:  Respir Med       Date:  2016-07-28       Impact factor: 3.415

Review 9.  The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.

Authors:  Fernando J Martinez; Alison Chisholm; Harold R Collard; Kevin R Flaherty; Jeffrey Myers; Ganesh Raghu; Simon L F Walsh; Eric S White; Luca Richeldi
Journal:  Lancet Respir Med       Date:  2016-12-06       Impact factor: 30.700

10.  Timolol-induced interstitial lung disease.

Authors:  Hetain Patel; Lina Vanessa Wilches; Jorge Guerrero
Journal:  Respir Med Case Rep       Date:  2015-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.